Agios Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Agios Pharma (AGIO) Misses Q3 EPS by 3c
November 1, 2018 7:08 AM EDTAgios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.63), $0.03 worse than the analyst estimate of ($1.60). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $20.08 million.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... More